College of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang 330045, China.
Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
Molecules. 2024 Mar 16;29(6):1328. doi: 10.3390/molecules29061328.
()-Homobenzylic amines are key structural motifs present in ()-selegiline, a drug indicated for the treatment of early-stage Parkinson's disease. Herein, we report a new short chemoenzymatic approach (in 2 steps) towards the synthesis of ()-selegiline via stereoselective biocatalytic reductive amination as the key step. The imine reductase IR36-M5 mutant showed high conversion (97%) and stereoselectivity (97%) toward the phenylacetone and propargyl amine substrates, offering valuable biocatalysts for synthesizing alkylated homobenzylic amines.
()-苯甲基胺是司来吉兰(一种用于治疗早期帕金森病的药物)中的关键结构基序。在此,我们报告了一种新的短化学酶法(分两步)合成()-司来吉兰的方法,其中立体选择性生物催化还原胺化为关键步骤。亚胺还原酶 IR36-M5 突变体对苯乙酮和炔丙胺底物表现出高转化率(97%)和立体选择性(97%),为合成烷基化的苯甲基胺提供了有价值的生物催化剂。